Tunisia Pharmaceutical Market Size Is Projected To Reach USD 3.4 Billion By 2028
San Francisco, 12 July 2021: The Report Tunisia Pharmaceutical Market Size, Share & Trends Analysis Report By Formulation (Tablets, Injectables, Sprays (BFS-mode, Non-BFS-mode), Suspensions, Capsules, Powders), And Segment Forecasts, 2021 - 2028 The Tunisia pharmaceutical market size is estimated to reach USD 3.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.9% from 2021 to 2028. The market is largely driven by the improving pharmaceutical exports of Tunisia, which is a result of expanding pool of local pharmaceutical manufacturers in the country. The country continues to explore and capitalize on export markets, prominently Francophone countries in Africa. Manufacturers are also engaged in on-site production in sub-Saharan nations. For instance, Tunisia-based Teriak acquired Cameroon’s Cinpharm plant in late 2015 to export in Central African markets. Despite the fact that Tunisian pharma companies have